|Bid||9.06 x 800|
|Ask||24.00 x 900|
|Day's Range||21.77 - 22.74|
|52 Week Range||15.44 - 26.90|
|Beta (5Y Monthly)||1.42|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Dec 09, 2015|
|1y Target Est||29.15|
Second Quarter and Recent Business Highlights:
Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences.
Artivion (AORT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).